Co-targeting Driver Pathways: Efficacy and Safety

Diagnostic Symposium

Dr. Derek Lyle, Chief Medical Officer, Clinical Services, will be hosting our Diagnostic Symposium featuring Dr. Razelle Kurzrock, who will speak on "Co-targeting Driver Pathways: Efficacy and Safety" at this virtual session

Dr Razelle Kurzrock will discuss the following:

  1. How to target pathways in cancer when there is more than one driver
  2. Efficacy of customized combinations
  3. How to safely combine drugs based on the IPREDICT (Nature Medicine 2019) experience

Derek Lyle

Written By:

DerekLyle.jpeg
Derek Lyle, MD
Chief Medical Officer of Clinical Services

Dr. Lyle joined NeoGenomics in 2018. Before joining NeoGenomics, Dr. Lyle worked at Genoptix Medical Laboratory for 9 years, where he initially served as Director of Hematopathology and, later, as Medical Director and Chief Medical Officer. Prior to joining Genoptix, Dr. Lyle worked as a surgical pathologist in Palm Springs, CA. Dr. Lyle completed combined Anatomic Pathology and Clinical Pathology residency training at Cedars-Sinai Medical Center in Los Angeles, CA, where he served as Chief Resident, and a Hematopathology fellowship at City of Hope National Medical Center.

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients